Panacea Biotec jumps 9% on manufacturing licence for Sputnik V vaccine
Panacea Biotec said on Sunday the Indian drugs regulator granted the licence following the company's collaboration with the Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund which markets the shot internationally.